Amman Pharmaceutical Industries Signs a Licensing Agreement with HUONS
Home » News » Amman Pharmaceutical Industries Signs a Licensing Agreement with HUONS
Amman Pharmaceutical Industries Signs a Licensing Agreement with HUONS
Tuesday, December 13, 2016

AMMAN, Dec. 13, 2016

Amman Pharmaceutical Industries is proud to annouce the completion and signing of a long term agreement with its future strategic partners HUONS Korea for an innovative dry eye treatment product which is considered a breakthrough in the ophthalmology world. This product will be available to patients in the MENA region under Amman Pharmaceutical Industries' brand and throughout our distribution networks late 2017.